StreetAlpha.app
Home › Stocks › LEXX

Lexaria Bioscience Corp. (LEXX)

$4.40
▼ −0.90%
LAST CLOSE · NOV 17

Lexaria Bioscience licenses DehydraTECH, a technology that improves how active ingredients are absorbed, to drug and consumer product makers. It last closed at $4.40 on Nov 17, down 0.90% on the day. LEXX reports earnings on Tue, Nov 24, 2026.

AI Auto Pilots
Is LEXX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$194K
−68.5% vs a year ago
Net income
−$7.7M
−3985.6% margin
EPS (diluted)
−$0.34
Free cash flow
−$7.5M
−3848.6% margin
Valuation
Market cap
$109.1M
24.8M shares
P/E
–
No P/E while losing money
Price to sales
562.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$3.5M
At May 31
Shareholder equity
$4.7M
Shares outstanding
24.8M
At Jul 13
Fiscal year endsAugust
ExchangeNasdaq
Financials history
FY2021: $723K$723KFY2021FY2022: $255K$255KFY2022FY2023: $226K$226KFY2023FY2024: $464K$464KFY2024FY2025: $706K$706KFY2025

From LEXX's SEC filings, latest 10-Q for the period ending May 31, 2026 (filed Jul 13). Last 12 months adds up the four latest quarters.

Next report
Nov 24
2026 · Time not announced
Consensus EPS forecast
-$0.90
$50,000 revenue est.
Year-ago EPS
-$0.14
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Technical Analysis

LEXX · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 12% above its 20 day and 20% above its 50 day average. It is 93% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 58). The nearest support is the Pivot at $4.33, and the nearest resistance the Pivot R1 at $4.47.

Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityNormal, 10.5%/day
Key levels
$21.6052 week high+390.9%
$8.51200 day average+93.4%
$6.22100 day average+41.4%
$4.79Swing high (Nov 10)+8.9%
$4.47Pivot R1+1.6%
$4.40Last close
$4.33Pivot−1.6%
$4.25Pivot S1−3.4%
$4.21Swing low (Aug 3)−4.3%
$3.8620 day average−12.3%
$3.5250 day average−20.0%
$2.4352 week low−44.8%
Indicators
RSI (14)57.84Middle of its rangeNeutral
MACD0.20Above its signal lineBullish
Stochastic79.4Middle of its rangeNeutral
ADX (14)18.6No clear trend
Williams %R-22.9Oversold below −80, overbought above −20Neutral
CCI (20)61.8Oversold below −100, overbought above 100Neutral
Rate of change+14.0%Change over 10 sessionsBullish
ATR (14)$0.46Typical daily range, 10.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
What happened before, for LEXX

What happened before

See how LEXX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Earnings in 6 daysSignals right before a report are less reliable. The report can override them.
November seasonalityHow LEXX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How LEXX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in LEXX in the last 90 days.

Loading…

See today’s whale options flow across the market →

LEXX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼15 buying vs 31 selling
  • ▼Held by funds -5.6 pts
  • ▼Funds holding -16
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1531−51.6%
In funds' top 1000–
Held by funds1.0%6.7%−5.6 pts
New / increased15 / 06 / 10−6.3%
Reduced / sold out0 / 316 / 3+244.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LEXX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LEXX is in one of them and how their past LEXX trades turned out.

LEXX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LEXX in an article yet. Here's the latest on the wider market.

About Lexaria Bioscience

Lexaria Bioscience is a biotechnology company based in Kelowna, British Columbia, Canada. It develops DehydraTECH, a technology that combines active ingredients with certain fatty acid rich oils so the body absorbs them more effectively. The technology can be used in tablets, capsules, oral suspensions, beverages and oral pouches. Lexaria licenses DehydraTECH to drug, nutraceutical and consumer product makers, who build it into their own products.

Headquarters
Kelowna, British Columbia, Canada